Construction
Compare Stocks
5 / 10Stock Comparison
BXC vs SITE vs BLDR vs IBP vs MAS
Revenue, margins, valuation, and 5-year total return — side by side.
Industrial - Distribution
Construction
Residential Construction
Construction
BXC vs SITE vs BLDR vs IBP vs MAS — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Construction | Industrial - Distribution | Construction | Residential Construction | Construction |
| Market Cap | $408M | $5.36B | $8.56B | $5.93B | $14.47B |
| Revenue (TTM) | $2.98B | $4.71B | $14.82B | $2.95B | $7.68B |
| Net Income (TTM) | $-4M | $153M | $292M | $255M | $837M |
| Gross Margin | 15.0% | 34.9% | 29.9% | 33.9% | 35.4% |
| Operating Margin | 0.9% | 5.1% | 4.2% | 12.7% | 16.8% |
| Forward P/E | 58.2x | 27.9x | 18.0x | 19.9x | 16.8x |
| Total Debt | $674M | $980M | $5.65B | $1.05B | $3.44B |
| Cash & Equiv. | $386M | $191M | $182M | $322M | $647M |
BXC vs SITE vs BLDR vs IBP vs MAS — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| BlueLinx Holdings I… (BXC) | 100 | 759.3 | +659.3% |
| SiteOne Landscape S… (SITE) | 100 | 113.8 | +13.8% |
| Builders FirstSourc… (BLDR) | 100 | 371.9 | +271.9% |
| Installed Building … (IBP) | 100 | 342.2 | +242.2% |
| Masco Corporation (MAS) | 100 | 153.8 | +53.8% |
Price return only. Dividends and distributions are not included.
Quick Verdict: BXC vs SITE vs BLDR vs IBP vs MAS
Each card shows where this stock fits in a portfolio — not just who wins on paper.
BXC lags the leaders in this set but could rank higher in a more targeted comparison.
SITE is the #2 pick in this set and the best alternative if growth exposure and sleep-well-at-night is your priority.
- Rev growth 3.6%, EPS growth 24.4%, 3Y rev CAGR 5.4%
- Lower volatility, beta 1.15, Low D/E 58.2%, current ratio 2.47x
- 3.6% revenue growth vs BLDR's -7.4%
- Beta 1.15 vs BXC's 2.01, lower leverage
Among these 5 stocks, BLDR doesn't own a clear edge in any measured category.
IBP ranks third and is worth considering specifically for long-term compounding and valuation efficiency.
- 6.6% 10Y total return vs BXC's 6.7%
- PEG 0.82 vs SITE's 6.72
- Lower P/E (19.9x vs 27.9x), PEG 0.82 vs 6.72
- +37.3% vs BLDR's -30.3%
MAS carries the broadest edge in this set and is the clearest fit for income & stability and defensive.
- Dividend streak 12 yrs, beta 1.28, yield 1.7%
- Beta 1.28, yield 1.7%, current ratio 1.81x
- 10.9% margin vs BXC's -0.1%
- 1.7% yield, 12-year raise streak, vs IBP's 1.5%, (3 stocks pay no dividend)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 3.6% revenue growth vs BLDR's -7.4% | |
| Value | Lower P/E (19.9x vs 27.9x), PEG 0.82 vs 6.72 | |
| Quality / Margins | 10.9% margin vs BXC's -0.1% | |
| Stability / Safety | Beta 1.15 vs BXC's 2.01, lower leverage | |
| Dividends | 1.7% yield, 12-year raise streak, vs IBP's 1.5%, (3 stocks pay no dividend) | |
| Momentum (1Y) | +37.3% vs BLDR's -30.3% | |
| Efficiency (ROA) | 15.9% ROA vs BXC's -0.3%, ROIC 35.4% vs 2.9% |
BXC vs SITE vs BLDR vs IBP vs MAS — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
BXC vs SITE vs BLDR vs IBP vs MAS — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
MAS leads in 3 of 6 categories
BXC leads 1 • IBP leads 1 • SITE leads 0 • BLDR leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
MAS leads this category, winning 6 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
BLDR is the larger business by revenue, generating $14.8B annually — 5.0x IBP's $2.9B. MAS is the more profitable business, keeping 10.9% of every revenue dollar as net income compared to BXC's -0.1%. On growth, MAS holds the edge at +6.5% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $3.0B | $4.7B | $14.8B | $2.9B | $7.7B |
| EBITDAEarnings before interest/tax | $70M | $382M | $1.2B | $656M | $1.4B |
| Net IncomeAfter-tax profit | -$4M | $153M | $292M | $255M | $837M |
| Free Cash FlowCash after capex | $31M | $246M | $862M | $63M | $943M |
| Gross MarginGross profit ÷ Revenue | +15.0% | +34.9% | +29.9% | +33.9% | +35.4% |
| Operating MarginEBIT ÷ Revenue | +0.9% | +5.1% | +4.2% | +12.7% | +16.8% |
| Net MarginNet income ÷ Revenue | -0.1% | +3.2% | +2.0% | +8.6% | +10.9% |
| FCF MarginFCF ÷ Revenue | +1.0% | +5.2% | +5.8% | +2.1% | +12.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.1% | +0.1% | -10.1% | -3.5% | +6.5% |
| EPS Growth (YoY)Latest quarter vs prior year | -154.5% | +1.6% | -151.2% | -21.3% | +20.7% |
Valuation Metrics
BXC leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 18.6x trailing earnings, MAS trades at a 99% valuation discount to BXC's 1898.2x P/E. Adjusting for growth (PEG ratio), IBP offers better value at 0.93x vs SITE's 8.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $408M | $5.4B | $8.6B | $5.9B | $14.5B |
| Enterprise ValueMkt cap + debt − cash | $696M | $6.2B | $14.0B | $6.7B | $17.3B |
| Trailing P/EPrice ÷ TTM EPS | 1898.19x | 35.91x | 19.90x | 22.66x | 18.59x |
| Forward P/EPrice ÷ next-FY EPS est. | 58.21x | 27.89x | 18.03x | 19.88x | 16.79x |
| PEG RatioP/E ÷ EPS growth rate | — | 8.65x | 2.52x | 0.93x | 3.75x |
| EV / EBITDAEnterprise value multiple | 9.61x | 16.23x | 10.18x | 13.58x | 12.16x |
| Price / SalesMarket cap ÷ Revenue | 0.14x | 1.14x | 0.56x | 1.99x | 1.91x |
| Price / BookPrice ÷ Book value/share | 0.67x | 3.24x | 1.99x | 8.38x | 200.89x |
| Price / FCFMarket cap ÷ FCF | 12.41x | 21.72x | 10.03x | 19.70x | 16.71x |
Profitability & Efficiency
MAS leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
MAS delivers a 8.0% return on equity — every $100 of shareholder capital generates $8 in annual profit, vs $-1 for BXC. SITE carries lower financial leverage with a 0.58x debt-to-equity ratio, signaling a more conservative balance sheet compared to MAS's 45.81x. On the Piotroski fundamental quality scale (0–9), SITE scores 8/9 vs BLDR's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -0.7% | +9.1% | +6.9% | +37.5% | +8.0% |
| ROA (TTM)Return on assets | -0.3% | +4.6% | +2.6% | +12.2% | +15.9% |
| ROICReturn on invested capital | +2.9% | +7.3% | +6.4% | +20.7% | +35.4% |
| ROCEReturn on capital employed | +2.4% | +9.6% | +8.5% | +22.6% | +35.9% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 8 | 5 | 8 | 6 |
| Debt / EquityFinancial leverage | 1.09x | 0.58x | 1.30x | 1.48x | 45.81x |
| Net DebtTotal debt minus cash | $288M | $789M | $5.5B | $731M | $2.8B |
| Cash & Equiv.Liquid assets | $386M | $191M | $182M | $322M | $647M |
| Total DebtShort + long-term debt | $674M | $980M | $5.6B | $1.1B | $3.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.69x | 6.79x | 2.19x | 9.47x | 12.60x |
Total Returns (Dividends Reinvested)
IBP leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in IBP five years ago would be worth $18,172 today (with dividends reinvested), compared to $6,008 for SITE. Over the past 12 months, IBP leads with a +37.3% total return vs BLDR's -30.3%. The 3-year compound annual growth rate (CAGR) favors IBP at 26.2% vs BLDR's -12.0% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -13.8% | -3.2% | -26.0% | -16.9% | +11.8% |
| 1-Year ReturnPast 12 months | -22.7% | -0.3% | -30.3% | +37.3% | +18.3% |
| 3-Year ReturnCumulative with dividends | -29.4% | -21.3% | -31.9% | +101.1% | +39.7% |
| 5-Year ReturnCumulative with dividends | -22.5% | -39.9% | +48.0% | +81.7% | +15.4% |
| 10-Year ReturnCumulative with dividends | +670.4% | +353.7% | +596.0% | +660.5% | +151.5% |
| CAGR (3Y)Annualised 3-year return | -10.9% | -7.7% | -12.0% | +26.2% | +11.8% |
Risk & Volatility
Evenly matched — SITE and MAS each lead in 1 of 2 comparable metrics.
Risk & Volatility
SITE is the less volatile stock with a 1.15 beta — it tends to amplify market swings less than BXC's 2.01 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. MAS currently trades 90.6% from its 52-week high vs BLDR's 51.2% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.01x | 1.15x | 1.66x | 1.31x | 1.28x |
| 52-Week HighHighest price in past year | $88.30 | $168.56 | $151.03 | $349.00 | $79.19 |
| 52-Week LowLowest price in past year | $44.84 | $112.23 | $73.40 | $150.83 | $58.16 |
| % of 52W HighCurrent price vs 52-week peak | +59.3% | +71.8% | +51.2% | +63.0% | +90.6% |
| RSI (14)Momentum oscillator 0–100 | 47.1 | 40.7 | 42.0 | 28.9 | 59.5 |
| Avg Volume (50D)Average daily shares traded | 109K | 690K | 2.4M | 345K | 2.7M |
Analyst Outlook
MAS leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: BXC as "Buy", SITE as "Buy", BLDR as "Buy", IBP as "Hold", MAS as "Buy". Consensus price targets imply 115.1% upside for BXC (target: $113) vs 14.2% for IBP (target: $251). For income investors, MAS offers the higher dividend yield at 1.73% vs IBP's 1.47%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Hold | Buy |
| Price TargetConsensus 12-month target | $112.67 | $162.29 | $106.64 | $251.33 | $82.60 |
| # AnalystsCovering analysts | 8 | 15 | 43 | 27 | 38 |
| Dividend YieldAnnual dividend ÷ price | — | — | — | +1.5% | +1.7% |
| Dividend StreakConsecutive years of raises | 4 | 2 | 2 | 5 | 12 |
| Dividend / ShareAnnual DPS | — | — | — | $3.24 | $1.24 |
| Buyback YieldShare repurchases ÷ mkt cap | +10.0% | +1.8% | +4.8% | +2.9% | +3.9% |
MAS leads in 3 of 6 categories (Income & Cash Flow, Profitability & Efficiency). BXC leads in 1 (Valuation Metrics). 1 tied.
BXC vs SITE vs BLDR vs IBP vs MAS: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is BXC or SITE or BLDR or IBP or MAS a better buy right now?
For growth investors, SiteOne Landscape Supply, Inc.
(SITE) is the stronger pick with 3. 6% revenue growth year-over-year, versus -7. 4% for Builders FirstSource, Inc. (BLDR). Masco Corporation (MAS) offers the better valuation at 18. 6x trailing P/E (16. 8x forward), making it the more compelling value choice. Analysts rate BlueLinx Holdings Inc. (BXC) a "Buy" — based on 8 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — BXC or SITE or BLDR or IBP or MAS?
On trailing P/E, Masco Corporation (MAS) is the cheapest at 18.
6x versus BlueLinx Holdings Inc. at 1898. 2x. On forward P/E, Masco Corporation is actually cheaper at 16. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Installed Building Products, Inc. wins at 0. 82x versus SiteOne Landscape Supply, Inc. 's 6. 72x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — BXC or SITE or BLDR or IBP or MAS?
Over the past 5 years, Installed Building Products, Inc.
(IBP) delivered a total return of +81. 7%, compared to -39. 9% for SiteOne Landscape Supply, Inc. (SITE). Over 10 years, the gap is even starker: BXC returned +670. 4% versus MAS's +151. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — BXC or SITE or BLDR or IBP or MAS?
By beta (market sensitivity over 5 years), SiteOne Landscape Supply, Inc.
(SITE) is the lower-risk stock at 1. 15β versus BlueLinx Holdings Inc. 's 2. 01β — meaning BXC is approximately 74% more volatile than SITE relative to the S&P 500. On balance sheet safety, SiteOne Landscape Supply, Inc. (SITE) carries a lower debt/equity ratio of 58% versus 46% for Masco Corporation — giving it more financial flexibility in a downturn.
05Which is growing faster — BXC or SITE or BLDR or IBP or MAS?
By revenue growth (latest reported year), SiteOne Landscape Supply, Inc.
(SITE) is pulling ahead at 3. 6% versus -7. 4% for Builders FirstSource, Inc. (BLDR). On earnings-per-share growth, the picture is similar: SiteOne Landscape Supply, Inc. grew EPS 24. 4% year-over-year, compared to -99. 6% for BlueLinx Holdings Inc.. Over a 3-year CAGR, SITE leads at 5. 4% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — BXC or SITE or BLDR or IBP or MAS?
Masco Corporation (MAS) is the more profitable company, earning 10.
7% net margin versus 0. 0% for BlueLinx Holdings Inc. — meaning it keeps 10. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: MAS leads at 16. 8% versus 1. 1% for BXC. At the gross margin level — before operating expenses — MAS leads at 35. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is BXC or SITE or BLDR or IBP or MAS more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Installed Building Products, Inc. (IBP) is the more undervalued stock at a PEG of 0. 82x versus SiteOne Landscape Supply, Inc. 's 6. 72x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Masco Corporation (MAS) trades at 16. 8x forward P/E versus 58. 2x for BlueLinx Holdings Inc. — 41. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BXC: 115. 1% to $112. 67.
08Which pays a better dividend — BXC or SITE or BLDR or IBP or MAS?
In this comparison, MAS (1.
7% yield), IBP (1. 5% yield) pay a dividend. BXC, SITE, BLDR do not pay a meaningful dividend and should not be held primarily for income.
09Is BXC or SITE or BLDR or IBP or MAS better for a retirement portfolio?
For long-horizon retirement investors, Installed Building Products, Inc.
(IBP) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (1. 5% yield, +660. 5% 10Y return). BlueLinx Holdings Inc. (BXC) carries a higher beta of 2. 01 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IBP: +660. 5%, BXC: +670. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between BXC and SITE and BLDR and IBP and MAS?
These companies operate in different sectors (BXC (Industrials) and SITE (Industrials) and BLDR (Industrials) and IBP (Consumer Cyclical) and MAS (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
IBP, MAS pay a dividend while BXC, SITE, BLDR do not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.